Regulatory circuitry governing fungal development, drug resistance, and disease.
Open accessThe DOI matches its Crossref record; 662 of the 662 references it cites were found in a registry or an index.
Abstract
SUMMARY: Pathogenic fungi have become a leading cause of human mortality due to the increasing frequency of fungal infections in immunocompromised populations and the limited armamentarium of clinically useful antifungal drugs. Candida albicans , Cryptococcus neoformans , and Aspergillus fumigatus are the leading causes of opportunistic fungal infections. In these diverse pathogenic fungi, complex signal transduction cascades are critical for sensing environmental changes and mediating appropriate cellular responses. For C. albicans , several environmental cues regulate a morphogenetic switch from yeast to filamentous growth, a reversible transition important for virulence. Many of the signaling cascades regulating morphogenesis are also required for cells to adapt and survive the cellular stresses imposed by antifungal drugs. Many of these signaling networks are conserved in C. neoformans and A. fumigatus , which undergo distinct morphogenetic programs during specific phases of their life cycles. Furthermore, the key mechanisms of fungal drug resistance, including alterations of the drug target, overexpression of drug efflux transporters, and alteration of cellular stress responses, are conserved between these species. This review focuses on the circuitry regulating fungal morphogenesis and drug resistance and the impact of these pathways on virulence. Although the three human-pathogenic fungi highlighted in this review are those most frequently encountered in the clinic, they represent a minute fraction of fungal diversity. Exploration of the conservation and divergence of core signal transduction pathways across C. albicans , C. neoformans , and A. fumigatus provides a foundation for the study of a broader diversity of pathogenic fungi and a platform for the development of new therapeutic strategies for fungal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 1,3-β-D-glucan synthases are encoded by FKS1, FKS2, and FKS3 in S. cerevisiae, C. glabrata, and C. albicans, and require a regulatory subunit encoded by RHO1 for activity [3], [20], [32], [33].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mechanisms of acquired resistance mostly fall into two classes (Figure 1B): (i) mutations leading to increased expression of the target or the alteration of its binding affinity towards the drug; and (ii) mutations leading to reduced intracellular accumulation of the drug by means of increasing the activity or expression of drug efflux pumps or, conversely, reducing the import of the drug [69].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, resistant strains with no known resistance-conferring mutations in target genes have also been reported [6,69], implying the presence of yet undiscovered mechanisms.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [69]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition by azoles commonly leads to depletion of ergosterol and accumulation of other sterols, such as lanosterol, eburicol and the toxic 14α-methyl-3,6-diol, within fungal cell membranes (Watson et al., 1989; Shapiro et al., 2011; Chen et al., 2016).”
From Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles (2018) · cites this paper as Shapiro et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of antifungal drugs in the clinic targeting the biosynthesis of ergosterol inhibit the activities of ERG enzymes and direct the biosynthesis of the ergosterol pathway to an alternative route”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [40]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–600 of 662
The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest
Bartlett, K. H., Kidd, S. E., & Kronstad, J. W. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0011-1 · Cited by 115
Variability of Germinative Potential among Pathogenic Species of Aspergillus
Araujo, R., & Rodrigues, A. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4335-4337.2004 · Cited by 114
Cowen, L. E., Kohn, L. M., & Anderson, J. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.2971-2978.2001 · Cited by 113
Self-citationAdherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole
Mateus, C., Crow, S. A., & Ahearn, D. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3358-3366.2004 · Cited by 113 · cited 1×
“This change in the resistance profile occurs in as little as 2 h after surface adherence (372).”
BackgroundCDC42 Is Required for Polarized Growth in Human Pathogen Candida albicans
Ushinsky, S. C., Harcus, D., Ash, J., Dignard, D., Marcil, A., Morchhauser, J., Thomas, D. Y., Whiteway, M., & Leberer, E. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.1.95-104.2002 · Cited by 113
Román, E., Cottier, F., Ernst, J. F., & Pla, J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00081-09 · Cited by 113 · cited 8×
“Intriguingly, recent evidence suggests that Cek1 can be regulated directly by environmental cues.”
BackgroundInfluentialSheng, C., Miao, Z., Ji, H., Yao, J., Wang, W., Che, X., Dong, G., Lü, J., Guo, W., & Zhang, W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01630-08 · Cited by 113
García-Sánchez, S., Mavor, A. L., Russell, C. L., Argimon, S., Dennison, P., Enjalbert, B., & Brown, A. J. P. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0071 · Cited by 112
Nobbs, A. H., Vickerman, M. M., & Jenkinson, H. F. (2010) · Eukaryotic Cell · doi:10.1128/ec.00103-10 · Cited by 112 · cited 1×
“For instance, the expression of Als1 allows binding to epithelial cells (194), while the expression of the Als3 and Hwp1 proteins allows binding to fibrinogen and the salivary pellicle, and the expression of Eap1 proteins allows binding to polystyrene surfaces (420).”
BackgroundThe Candida albicans Cdr2p ATP‐binding cassette (ABC) transporter confers resistance to caspofungin
Schuetzer‐Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., & Kuchler, K. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03430.x · Cited by 111
Azole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
Mansfield, B. E., Oltean, H. N., Oliver, B. G., Hoot, S. J., Leyde, S. E., Hedstrom, L., & White, T. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001126 · Cited by 111
Transcriptional Regulation by Protein Kinase A in Cryptococcus neoformans
Hu, G., Steen, B. R., Lian, T., Sham, A. P., Tam, N., Tangen, K. L., & Kronstad, J. W. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030042 · Cited by 111
Kontoyiannis, D. P., Ratanatharathorn, V., Young, J. ‐., Raymond, J., Laverdière, M., Denning, D. W., Patterson, T. F., Facklam, D., Kovanda, L., Arnold, L., et al. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2008.00349.x · Cited by 111
Martinez-Lopez, R. (2004) · Microbiology · doi:10.1099/mic.0.27320-0 · Cited by 111
Hyphal Elongation Is Regulated Independently of Cell Cycle in Candida albicans
Hazan, I., Sepulveda-Becerra, M., & Liu, H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-03-0116 · Cited by 111
Fries, B. C., Taborda, C. P., Serfass, E., & Casadevall, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13407 · Cited by 111
The Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion
Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., & Lopez-Ribot, J. L. (2010) · Eukaryotic Cell · doi:10.1128/ec.00111-10 · Cited by 110
Efficacy of Orally Delivered Cochleates Containing Amphotericin B in a Murine Model of Aspergillosis
Delmas, G., Park, S., Chen, Z. W., Tan, F., Kashiwazaki, R., Zarif, L., & Perlin, D. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2704-2707.2002 · Cited by 110
Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin
Gardiner, R. E., Souteropoulos, P., Park, S., & Perlin, D. S. (2005) · Medical Mycology · doi:10.1080/13693780400029023 · Cited by 110
Mai, A., Rotili, D., Massa, S., Brosch, G., Simonetti, G., Passariello, C., & Palamara, A. T. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.028 · Cited by 109
Vandeputte, P., Tronchin, G., Bergès, T., Hennequin, C., Chabasse, D., & Bouchara, J.-P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-06 · Cited by 109 · cited 2×
“Complementation with a wildtype copy of ERG6 restored polyene susceptibility (598).”
BackgroundEstimating the Cost of Nosocomial Candidemia in the United States
Miller, L. G., Hajjeh, R. A., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/319613 · Cited by 109 · cited 1×
“Species of Candida are the fourth most common cause of hospital-acquired infectious diseases in the United States, costing the health care system an estimated $1 billion annually (120, 382).”
BackgroundCramer, K. L., Gerrald, Q. D., Nichols, C. B., Price, M. S., & Alspaugh, J. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00145-06 · Cited by 108
Calcineurin Inhibition or Mutation Enhances Cell Wall Inhibitors against Aspergillus fumigatus
Steinbach, W. J., Cramer, R. A., Perfect, B. Z., Henn, C., Nielsen, K., Heitman, J., & Perfect, J. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01394-06 · Cited by 108 · cited 2×
“The deletion of cnaA, which encodes the catalytic subunit of calcineurin, similarly enhances the efficacy of caspofungin (558).”
BackgroundPorta, A., Ramon, A. M., & Fonzi, W. A. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.24.7516-7523.1999 · Cited by 108
White, T., Pfaller, M., Rinaldi, M., Smith, J., & Redding, S. (1997) · Oral Diseases · doi:10.1111/j.1601-0825.1997.tb00336.x · Cited by 107 · cited 1×
“This widespread deployment of azoles coupled with the fungistatic nature of these drugs has led to the emergence of azole resistance in clinical isolates (13, 111, 120, 507, 624).”
BackgroundCaspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5729-5731.2003 · Cited by 107
High Prevalence of Cryptococcus neoformans var. gattii in Tropical and Subtropical Regions
Kwon-Chung, K. J., & Bennett, J. E. (1984) · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie · doi:10.1016/s0174-3031(84)80074-8 · Cited by 107
Waugh, M. S., Nichols, C. B., DeCesare, C. M., Cox, G. M., Heitman, J., & Alspaugh, J. A. (2002) · Microbiology · doi:10.1099/00221287-148-1-191 · Cited by 106
Diverged Binding Specificity of Rim101p, the Candida albicans Ortholog of PacC
Ramón, A. M., & Fonzi, W. A. (2003) · Eukaryotic Cell · doi:10.1128/ec.2.4.718-728.2003 · Cited by 106
Gerik, K. J., Bhimireddy, S. R., Ryerse, J. S., Specht, C. A., & Lodge, J. K. (2008) · Eukaryotic Cell · doi:10.1128/ec.00146-08 · Cited by 106
Johnson, E. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.85 · Cited by 106
Aspergillus fumigatus: virulence genes in a street-smart mold
Askew, D. S. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.05.009 · Cited by 105
Integrative analysis of the heat shock response in Aspergillus fumigatus
Albrecht, D., Guthke, R., Brakhage, A. A., & Kniemeyer, O. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-32 · Cited by 105
Schuetzer‐Muehlbauer, M., Willinger, B., Egner, R., Ecker, G., & Kuchler, K. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00213-9 · Cited by 103
Heteroresistance of Cryptococcus gattii to Fluconazole
Varma, A., & Kwon-Chung, K. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-10 · Cited by 103
Krishnarao, T. V., & Galgiani, J. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1957 · Cited by 102
A Morphology Index for Characterization of Cell Shape in Candida albicans
Merson-Davies, L. A., & Odds, F. C. (1989) · Microbiology · doi:10.1099/00221287-135-11-3143 · Cited by 102
Hicks, J. K., D'Souza, C. A., Cox, G. M., & Heitman, J. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.1.14-26.2004 · Cited by 102
Bachewich, C., Nantel, A., & Whiteway, M. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04727.x · Cited by 101
Timpel, C., Zink, S., Strahl-Bolsinger, S., Schröppel, K., & Ernst, J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3063-3071.2000 · Cited by 101
Jones, L. A., & Sudbery, P. E. (2010) · Eukaryotic Cell · doi:10.1128/ec.00109-10 · Cited by 99
Candida albicans Rim13p, a Protease Required for Rim101p Processing at Acidic and Alkaline pHs
Li, M., Martin, S. J., Bruno, V. M., Mitchell, A. P., & Davis, D. A. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.741-751.2004 · Cited by 99
MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98 · cited 2×
“assays and mouse models of systemic candidiasis (350).”
BackgroundFungal virulence studies come of age.
Odds, F. C., Gow, N. A. R., & Brown, A. J. P. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews1009 · Cited by 98
The DNA Binding Protein Rfg1 Is a Repressor of Filamentation in Candida albicans
Khalaf, R. A., & Zitomer, R. S. (2001) · Genetics · doi:10.1093/genetics/157.4.1503 · Cited by 97
El Barkani, A., Kurzai, O., Fonzi, W. A., Ramon, A., Porta, A., Frosch, M., & Mühlschlegel, F. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4635-4647.2000 · Cited by 96
Mechanisms of Cryptococcal Virulence and Persistence
Olszewski, M. A., Zhang, Y., & Huffnagle, G. B. (2010) · Future Microbiology · doi:10.2217/fmb.10.93 · Cited by 96
Giusani, A. D., Vinces, M., & Kumamoto, C. A. (2002) · Genetics · doi:10.1093/genetics/160.4.1749 · Cited by 96
Bruns, S., Seidler, M., Albrecht, D., Salvenmoser, S., Remme, N., Hertweck, C., Brakhage, A. A., Kniemeyer, O., & Müller, F. C. (2010) · PROTEOMICS · doi:10.1002/pmic.201000129 · Cited by 95
Osherov, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.75 · Cited by 95
Zhao, W., Panepinto, J. C., Fortwendel, J. R., Fox, L., Oliver, B. G., Askew, D. S., & Rhodes, J. C. (2006) · Infection and Immunity · doi:10.1128/iai.00565-06 · Cited by 95
Cryptococcosis: clinical and biological aspects
Kwon-Chung, K. J., Sorrell, T. C., Dromer, F., Fung, E., & Levitz, S. M. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.205.213 · Cited by 94
CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1
Chen, C.-G., Yang, Y.-L., Shih, H.-I., Su, C.-L., & Lo, H.-J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4505-4512.2004 · Cited by 94
The Mitotic Cyclins Clb2p and Clb4p Affect Morphogenesis in Candida albicans
Bensen, E. S., Clemente-Blanco, A., Finley, K. R., Correa-Bordes, J., & Berman, J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1081 · Cited by 94 · cited 1×
“The depletion of either Clb2 or Clb4 causes filamentation: Clb2-depleted cells are inviable and arrest with hyperelongated projections, while Clb4-depleted cells are viable and are constitutively pseudohyphal (47).”
BackgroundIn Vivo and In Vitro Anaerobic Mating in Candida albicans
Dumitru, R., Navarathna, D. H. M. L. P., Semighini, C. P., Elowsky, C. G., Dumitru, R. V., Dignard, D., Whiteway, M., Atkin, A. L., & Nickerson, K. W. (2007) · Eukaryotic Cell · doi:10.1128/ec.00316-06 · Cited by 94
Chong, H. S., Dagg, R. A., Malík, R., Chen, W., & Carter, D. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01271-10 · Cited by 93
Riggle, P. J., Andrutis, K. A., Chen, X., Tzipori, S. R., & Kumamoto, C. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.7.3649-3652.1999 · Cited by 91
Aspergillus fumigatus rasA and rasB regulate the timing and morphology of asexual development
Fortwendel, J. R., Panepinto, J. C., Seitz, A. E., Askew, D. S., & Rhodes, J. C. (2003) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2003.10.004 · Cited by 91
Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans
Sellam, A., Tebbji, F., & Nantel, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00074-09 · Cited by 91
Nichols, C. B., Perfect, Z. H., & Alspaugh, J. A. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05566.x · Cited by 91
Wang, P., & Heitman, J. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80063-0 · Cited by 90
Hyphal growth in Candida albicans requires the phosphorylation of Sec2 by the Cdc28‐Ccn1/Hgc1 kinase
Bishop, A., Lane, R., Beniston, R., Chapa‐y‐Lazo, B., Smythe, C., & Sudbery, P. E. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.158 · Cited by 90
Alejandro-Osorio, A. L., Huebert, D. J., Porcaro, D. T., Sonntag, M. E., Nillasithanukroh, S., Will, J. L., & Gasch, A. P. (2009) · Genome Biology · doi:10.1186/gb-2009-10-5-r57 · Cited by 90
Fortwendel, J. R., Zhao, W., Bhabhra, R., Park, S., Perlin, D. S., Askew, D. S., & Rhodes, J. C. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.12.1982-1989.2005 · Cited by 89
Cryptococcus neoformans of Unusual Morphology
Cruickshank, J. G., Cavill, R. H., & Jelbert, M. (1973) · Applied Microbiology · doi:10.1128/aem.25.2.309-312.1973 · Cited by 88
Romano, J., Nimrod, G., Ben-Tal, N., Shadkchan, Y., Baruch, K., Sharon, H., & Osherov, N. (2006) · Microbiology · doi:10.1099/mic.0.28936-0 · Cited by 88
Rad, M. R. (2003) · Current Genetics · doi:10.1007/s00294-003-0383-6 · Cited by 87
Reduced virulence of Candida albicans PHR1 mutants
Ghannoum, M. A., Spellberg, B., Saporito-Irwin, S. M., & Fonzi, W. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4528-4530.1995 · Cited by 87
Post, M. J., Lass‐Floerl, C., Gastl, G., & Nachbaur, D. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00219.x · Cited by 87
Sellam, A., Askew, C., Epp, E., Lavoie, H., Whiteway, M., & Nantel, A. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-11-1093 · Cited by 87
Bahn, Y., Staab, J., & Sundstrom, P. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03692.x · Cited by 87
Mouyna, I., Kniemeyer, O., Jank, T., Loussert, C., Mellado, E., Aimanianda, V., Beauvais, A., Wartenberg, D., Sarfati, J., Bayry, J., et al. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07164.x · Cited by 87
Barwell, K. J., Boysen, J. H., Xu, W., & Mitchell, A. P. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.5.890-899.2005 · Cited by 86
Renwick, J. A. A., Daly, P., Reeves, E. P., & Kavanagh, K. A. (2006) · Mycopathologia · doi:10.1007/s11046-006-0021-1 · Cited by 85
Warrilow, A. G. S., Melo, N., Martel, C. M., Parker, J. E., Nes, W. D., Kelly, S. L., & Kelly, D. E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-10 · Cited by 85
Cyclin Cln3p Links G 1 Progression to Hyphal and Pseudohyphal Development in Candida albicans
Bachewich, C., & Whiteway, M. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.1.95-102.2005 · Cited by 85
Kafadar, K. A., & Cyert, M. S. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.5.1147-1153.2004 · Cited by 85
Ha, K. C., & White, T. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.763 · Cited by 84
Depletion of a Polo-like Kinase in Candida albicans Activates Cyclase-dependent Hyphal-like Growth
Bachewich, C., Thomas, D. Y., & Whiteway, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-05-0076 · Cited by 84
Fang, H., & Wang, Y. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05248.x · Cited by 83
Korting, H. C., Hube, B., Oberbauer, S., Januschke, E., Hamm, G., Albrecht, A., Borelli, C., & Schaller, M. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05125-0 · Cited by 83
Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., & Prasad, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3442-3452.2005 · Cited by 83
Mukherjee, P. K., Long, L. A., Kim, H., & Ghannoum, M. A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.030 · Cited by 83
Palmer, D. A., Thompson, J. K., Li, L., Prat, A., & Wang, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602768200 · Cited by 83
Jain, P., Akula, I., & Edlind, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3195-3201.2003 · Cited by 82
Cross-resistance to polyene and azole drugs in Cryptococcus neoformans
Joseph-Horne, T., Hollomon, D., Loeffler, R. S., & Kelly, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1526 · Cited by 81
Apoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81 · cited 1×
“parapsilosis biofilms (5), although the mechanism remains unclear.”
BackgroundIdentification of the dialysable serum inducer of germ-tube formation in Candida albicans
Hudson, D. A., Sciascia, Q. L., Sanders, R. J., Norris, G. E., Edwards, P. J. B., Sullivan, P. A., & Farley, P. C. (2004) · Microbiology · doi:10.1099/mic.0.27121-0 · Cited by 81
Sellam, A., Askew, C., Epp, E., Tebbji, F., Mullick, A., Whiteway, M., & Nantel, A. (2010) · Eukaryotic Cell · doi:10.1128/ec.00325-09 · Cited by 81
Hyphal content determines the compression strength of Candida albicans biofilms
Paramonova, E., Krom, B. P., van der Mei, H. C., Busscher, H. J., & Sharma, P. K. (2009) · Microbiology · doi:10.1099/mic.0.021568-0 · Cited by 81
Chlamydospore Formation during Hyphal Growth in Cryptococcus neoformans
Lin, X., & Heitman, J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.10.1746-1754.2005 · Cited by 81
The G 1 Cyclin Cln3 Regulates Morphogenesis in Candida albicans
Chapa y Lazo, B., Bates, S., & Sudbery, P. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.1.90-94.2005 · Cited by 80
Efg1, a Morphogenetic Regulator in Candida albicans , Is a Sequence-Specific DNA Binding Protein
Leng, P., Lee, P. R., Wu, H., & Brown, A. J. P. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.13.4090-4093.2001 · Cited by 80
Olson, G. M., Fox, D. S., Wang, P., Alspaugh, J. A., & Buchanan, K. L. (2007) · Eukaryotic Cell · doi:10.1128/ec.00182-06 · Cited by 80
Heat-shock proteins and the host-pathogen interaction during bacterial infection.
Stewart, G. R., & Young, D. B. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.05.007 · Cited by 79 · cited 1×
“Given the in vitro activity, it is unlikely to work solely by influencing the host immune response to the pathogen, although heat shock proteins are often immunodominant antigens for pathogen recognition and mediate both innate and adaptive immune responses (548, 565).”
BackgroundLi, H., Zhou, H., Luo, Y., Ouyang, H., Hu, H., & Jin, C. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05709.x · Cited by 79
Rac1 and Cdc42 Have Different Roles in Candida albicans Development
Bassilana, M., & Arkowitz, R. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.2.321-329.2006 · Cited by 79
Soll, D. R. (2004) · BioEssays · doi:10.1002/bies.10379 · Cited by 79
Santos, M., & de Larrinoa, I. F. (2005) · Current Genetics · doi:10.1007/s00294-005-0003-8 · Cited by 78
Hyphal Tip-Associated Localization of Cdc42 Is F-Actin Dependent in Candida albicans
Hazan, I., & Liu, H. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.6.856-864.2002 · Cited by 78
Upton, A., Fraser, J. A., Kidd, S. E., Bretz, C., Bartlett, K. H., Heitman, J., & Marr, K. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00593-07 · Cited by 78
Rao, U. S., & Scarborough, G. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10165-x · Cited by 78
Large Cryptococcus neoformans isolated from brain abscess
Love, G. L., Boyd, G. D., & Greer, D. L. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.1068-1070.1985 · Cited by 77
Spiering, M. J., Moran, G. P., Chauvel, M., MacCallum, D. M., Higgins, J., Hokamp, K., Yeomans, T., d'Enfert, C., Coleman, D. C., & Sullivan, D. J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00291-09 · Cited by 77
Maeng, S., Ko, Y.-J., Kim, G.-B., Jung, K.-W., Floyd, A., Heitman, J., & Bahn, Y.-S. (2010) · Eukaryotic Cell · doi:10.1128/ec.00309-09 · Cited by 77
Kan, V. L., & Bennett, J. E. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.2.407 · Cited by 77
Cytoplasmic Alkalinization during Germ Tube Formation in Candida albicans
STEWART, E., GOW, N. A. R., & BOWEN, D. V. (1988) · Microbiology · doi:10.1099/00221287-134-5-1079 · Cited by 76
Cryptococcus neoformans: virulence and host defences.
Perfect, J. R., Wong, B., Chang, Y. C., Kwon-Chung, K. J., & Williamson, P. R. (1998) · PubMed · Cited by 75
Kamran, M., Calcagno, A.-M., Findon, H., Bignell, E., Jones, M. D., Warn, P., Hopkins, P., Denning, D. W., Butler, G., Rogers, T., et al. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.546-552.2004 · Cited by 75 · cited 1×
“glabrata lacking Ace2 are hypervirulent (265, 271, 351).”
BackgroundGonzález-Novo, A., Correa-Bordes, J., Labrador, L., Sánchez, M., Vázquez de Aldana, C. R., & Jiménez, J. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0876 · Cited by 75
Aspergillus nidulans is frequently resistant to amphotericin B
Kontoyiannis, D. P., Lewis, R. E., May, G. S., Osherov, N., & Rinaldi, M. G. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00797.x · Cited by 75
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans
Venkateswarlu, K., Taylor, M., Manning, N. J., Rinaldi, M. G., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.748 · Cited by 74
Zou, H., Fang, H., Zhu, Y., & Wang, Y. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06980.x · Cited by 74
Berbee, M. L., Carmean, D., & Winka, K. (2000) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.2000.0835 · Cited by 74
Wang, A., Raniga, P. P., Lane, S., Lu, Y., & Liu, H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01502-08 · Cited by 74
Aspergillus fumigatus spore concentration in outside air: Cardiff and St Louis compared
MULLINS, J., HUTCHESON, P. S., & SLAVIN, R. G. (1984) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1984.tb02215.x · Cited by 73
Balashov, S. V., Gardiner, R., Park, S., & Perlin, D. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.214-222.2005 · Cited by 73
Calderon, J., Zavrel, M., Ragni, E., Fonzi, W. A., Rupp, S., & Popolo, L. (2010) · Microbiology · doi:10.1099/mic.0.038000-0 · Cited by 72 · cited 1×
“albicans, and the homozygous deletion of PHR1 results in reduced adhesion and invasive growth as well as abnormal septum formation (87).”
BackgroundThe cAMP phosphodiesterase encoded by CaPDE2 is required for hyphal development in Candida albicans
Jung, W. H., & Stateva, L. I. (2003) · Microbiology · doi:10.1099/mic.0.26517-0 · Cited by 72
Mutation of the Regulator of G Protein Signaling Crg1 Increases Virulence in Cryptococcus neoformans
Wang, P., Cutler, J., King, J., & Palmer, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.4.1028-1035.2004 · Cited by 72
Hawser, S. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.411 · Cited by 72
Brega, E., Zufferey, R., & Mamoun, C. B. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.1.135-143.2004 · Cited by 72
Manavathu, E. K., Cutright, J., & Chandrasekar, P. H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.858-861.1999 · Cited by 72
Shen, J., Cowen, L. E., Griffin, A. M., Chan, L., & Köhler, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809147105 · Cited by 71
Self-citationBahn, Y.-S., Geunes-Boyer, S., & Heitman, J. (2007) · Eukaryotic Cell · doi:10.1128/ec.00349-07 · Cited by 71
Román, E., Alonso-Monge, R., Gong, Q., Li, D., Calderone, R., & Pla, J. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00545.x · Cited by 70
Carlisle, P. L., & Kadosh, D. (2010) · Eukaryotic Cell · doi:10.1128/ec.00046-10 · Cited by 70
Andaluz, E., Ciudad, T., Gómez‐Raja, J., Calderone, R., & Larriba, G. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05038.x · Cited by 69
Zhou, H., Hu, H., Zhang, L., Li, R., Ouyang, H., Ming, J., & Jin, C. (2007) · Eukaryotic Cell · doi:10.1128/ec.00261-07 · Cited by 69
Kremer, S. B., & Gross, D. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058610 · Cited by 68
Warn, P. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg185 · Cited by 68
Heath, V. L., Shaw, S. L., Roy, S., & Cyert, M. S. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.695-704.2004 · Cited by 68
Armengou, A., Porcar, C., Mascaro, J., & Garcia-Bragado, F. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.6.1337-a · Cited by 68
Haploid fruiting in Cryptococcus neoformans is not mating type α-specific
Tscharke, R. L., Lazéra, M., Chang, Y. C., Wickes, B. L., & Kwon-Chung, K. J. (2003) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(03)00046-x · Cited by 68
Hsueh, Y., Xue, C., & Heitman, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0133 · Cited by 68
ODDS, F. C., COCKAYNE, A., HAYWARD, J., & ABBOTT, A. B. (1985) · Microbiology · doi:10.1099/00221287-131-10-2581 · Cited by 67
Resistance to amphotericin B: emerging clinical and microbiological patterns
Sterling, T. R., & Merz, W. G. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80034-4 · Cited by 66
A constitutively active GPCR governs morphogenic transitions in Cryptococcus neoformans
Hsueh, Y., Xue, C., & Heitman, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.68 · Cited by 66
Finley, K. R., & Berman, J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.10.1697-1711.2005 · Cited by 66 · cited 1×
“Nuclear division in hyphal cells occurs within the germ tube itself following nuclear migration (180).”
BackgroundVallim, M. A., Nichols, C. B., Fernandes, L., Cramer, K. L., & Alspaugh, J. A. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.6.1066-1078.2005 · Cited by 66
Manavathu, E. K., Vázquez, J. A., & Chandrasekar, P. H. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00102-2 · Cited by 65
Zaragoza, O., de Virgilio, C., Pontón, J., & Gancedo, C. (2002) · Microbiology · doi:10.1099/00221287-148-5-1281 · Cited by 65
Kullas, A. L., Li, M., & Davis, D. A. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1609-1618.2004 · Cited by 65
Bai, C., Ramanan, N., Wang, Y. M., & Wang, Y. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02995.x · Cited by 65
Organization of antibiotic amphotericin B in model lipid membranes. A mini review.
Gruszecki, W. I., Gagoś, M., Hereć, M., & Kernen, P. (2003) · PubMed · Cited by 64
Baek, Y.-U., Martin, S. J., & Davis, D. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00088-06 · Cited by 64
Vinces, M. D., Haas, C., & Kumamoto, C. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.5.5.825-835.2006 · Cited by 64
Candida albicans Sfl1 Suppresses Flocculation and Filamentation
Bauer, J., & Wendland, J. (2007) · Eukaryotic Cell · doi:10.1128/ec.00236-07 · Cited by 63
Bien, C. M., Chang, Y. C., Nes, W. D., Kwon‐Chung, K. J., & Espenshade, P. J. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06895.x · Cited by 62
Thornewell, S. J., Peery, R. B., & Skatrud, P. L. (1997) · Gene · doi:10.1016/s0378-1119(97)00421-6 · Cited by 62
Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Boyken, L., Hollis, R. J., Furuta, I., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.267-272.2003 · Cited by 62
Subcellular Localization Directs Signaling Specificity of the Cryptococcus neoformans Ras1 Protein
Nichols, C. B., Ferreyra, J., Ballou, E. R., & Alspaugh, J. A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00351-08 · Cited by 62
Tsao, C.-C., Chen, Y.-T., & Lan, C. (2008) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2008.11.008 · Cited by 61
Epp, E., Vanier, G., Harcus, D., Lee, A. Y., Jansen, G., Hallett, M., Sheppard, D. C., Thomas, D. Y., Munro, C. A., Mullick, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000753 · Cited by 61
Aspergillus fumigatus RasA Regulates Asexual Development and Cell Wall Integrity
Fortwendel, J. R., Fuller, K. K., Stephens, T. J., Bacon, W. C., Askew, D. S., & Rhodes, J. C. (2008) · Eukaryotic Cell · doi:10.1128/ec.00080-08 · Cited by 61
Segarra, I., Movshin, D. A., & Zarif, L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10173 · Cited by 60
Zhu, Y., Fang, H., Wang, Y., Zeng, G., Zheng, X., & Wang, Y. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06898.x · Cited by 60
Isolation and partial characterization of Hsp90 from Candida albicans.
Burt, E. T., Daly, R., Hoganson, D., Tsirulnikov, Y., Essmann, M., & Larsen, B. (2003) · PubMed · Cited by 59
Chang, Y. C., Miller, G., & Kwon-Chung, K. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.4953-4960.2003 · Cited by 59
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus
Araújo, R., Pina‐Vaz, C., & Rodrigues, A. G. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.019 · Cited by 59
Marchetti, O., Moreillon, P., Entenza, J. M., Vouillamoz, J., Glauser, M. P., Bille, J., & Sanglard, D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1565-1570.2003 · Cited by 58
Chang, Y. C., Ingavale, S. S., Bien, C., Espenshade, P., & Kwon-Chung, K. J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00207-09 · Cited by 58
Ma, Y., Qiao, J., Liu, W., Wan, Z., Wang, X., Calderone, R., & Li, R. (2008) · Infection and Immunity · doi:10.1128/iai.01507-07 · Cited by 57
Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya
Bii, C. C., Makimura, K., Abe, S., Taguchi, H., Mugasia, O. M., Revathi, G., Wamae, N. C., & Kamiya, S. (2007) · Mycoses · doi:10.1111/j.1439-0507.2006.01293.x · Cited by 57
Fan, W., Idnurm, A., Breger, J., Mylonakis, E., & Heitman, J. (2007) · Infection and Immunity · doi:10.1128/iai.01977-06 · Cited by 57 · cited 1×
“mellonella, and in the nematode Caenorhabditis elegans but are attenuated in virulence at 37°C (172).”
BackgroundCloning of a Cryptococcus neoformans gene, GPA1, encoding a G-protein alpha-subunit homolog
Tolkacheva, T., McNamara, P., Piekarz, E., & Courchesne, W. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2849-2856.1994 · Cited by 56
Wilson, D., Tutulan‐Cunita, A., Jung, W., Hauser, N. C., Hernandez, R., Williamson, T., Piekarska, K., Rupp, S., Young, T., & Stateva, L. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05788.x · Cited by 55
Dirr, F., Echtenacher, B., Heesemann, J., Hoffmann, P., Ebel, F., & Wagener, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.03.001 · Cited by 54
Karos, M., Chang, Y. C., McClelland, C. M., Clarke, D. L., Fu, J., Wickes, B. L., & Kwon-Chung, K. J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.21.6222-6227.2000 · Cited by 54
Regulation of azole drug susceptibility by Candida albicans protein kinase CK2
Bruno, V. M., & Mitchell, A. P. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04562.x · Cited by 54
Nosema ceranae, a new parasite in Thai honeybees
Suwannapong, G., Yemor, T., Boonpakdee, C., & Benbow, M. E. (2010) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2010.10.003 · Cited by 54
Neill, J. M., Abrahams, I., & Kapros, C. E. (1950) · Journal of Bacteriology · doi:10.1128/jb.59.2.263-275.1950 · Cited by 53
Fuller, K. K., Richie, D. L., Feng, X., Krishnan, K., Stephens, T. J., Wikenheiser‐Brokamp, K. A., Askew, D. S., & Rhodes, J. C. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07509.x · Cited by 53
Giacometti, R., Kronberg, F., Biondi, R. M., & Passeron, S. (2009) · Yeast · doi:10.1002/yea.1665 · Cited by 53
Roles of Candida albicans Sfl1 in Hyphal Development
Li, Y., Su, C., Mao, X., Cao, F., & Chen, J. (2007) · Eukaryotic Cell · doi:10.1128/ec.00199-07 · Cited by 53
Oliver, B. G., Song, J. L., Choiniere, J. H., & White, T. C. (2007) · Eukaryotic Cell · doi:10.1128/ec.00331-06 · Cited by 53 · cited 23×
“One study has shown that TSA blocks the azole-induced upregulation of ERG11, CDR1, and CDR2 (540).”
BackgroundInfluentialGehrke, A., Heinekamp, T., Jacobsen, I. D., & Brakhage, A. A. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00052-10 · Cited by 53
Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Monzon, A., Buitrago, M. J., & Rodriguez-Tudela, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01543-08 · Cited by 53
Gpa2, a G-Protein α Subunit Required for Hyphal Development in Candida albicans
Sánchez-Martínez, C., & Pérez-Martín, J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.6.865-874.2002 · Cited by 53
Human Neutrophil Degranulation Stimulated by Aspergillus fumigatus
Levitz, S. M., & Farrell, T. P. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.2.170 · Cited by 53
Hope, H., Bogliolo, S., Arkowitz, R. A., & Bassilana, M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-12-1272 · Cited by 52
Jones, D. L., Petty, J., Hoyle, D. C., Hayes, A., Ragni, E., Popolo, L., Oliver, S. G., & Stateva, L. I. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00139.2003 · Cited by 51
Molecular principles of fungal pathogenesis
Barnes, R. A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70105-6 · Cited by 49
HOYER, L. L., CIESLINSKI, L. B., MCLAUGHLIN, M. M., TORPHY, T. J., SHATZMAN, A. R., & LIVI, G. P. (1994) · Microbiology · doi:10.1099/13500872-140-7-1533 · Cited by 48
Molecular Analysis ofCPRα, aMATα-Specific Pheromone Receptor Gene ofCryptococcus neoformans
CHUNG, S. S., Karos, M., Chang, Y. C., Lukszo, J., Wickes, B. L., & Kwon-Chung, K. J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.3.432-439.2002 · Cited by 48
Laprade, L., Boyartchuk, V. L., Dietrich, W. F., & Winston, F. (2002) · Genetics · doi:10.1093/genetics/161.2.509 · Cited by 48
Hu, G., & Kronstad, J. W. (2010) · Eukaryotic Cell · doi:10.1128/ec.00289-09 · Cited by 47
Staab, J. F., Bahn, Y.-S., & Sundstrom, P. (2003) · Microbiology · doi:10.1099/mic.0.26445-0 · Cited by 47
Canonical Heterotrimeric G Proteins Regulating Mating and Virulence ofCryptococcus neoformans
Li, L., Shen, G., Zhang, Z.-G., Wang, Y., Thompson, J. K., & Wang, P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0136 · Cited by 47
Ejzykowicz, D. E., Cunha, M. M., Rozental, S., Solis, N. V., Gravelat, F. N., Sheppard, D. C., & Filler, S. G. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06631.x · Cited by 47
Prasad, T., Hameed, S., Manoharlal, R., Biswas, S., Mukhopadhyay, C. K., Goswami, S. K., & Prasad, R. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00639.x · Cited by 46 · cited 2×
“The efg1 mutant exhibited a 24% decrease in ergosterol production and showed an enhanced passive diffusion of radiolabeled fluconazole across the fungal membrane when grown on solid medium, which could potentially explain the increased azole susceptibility (467).”
BackgroundMaidan, M. M., Rop, L. D., Relloso, M., Diez‐Orejas, R., Thevelein, J. M., & Dijck, P. V. (2008) · Infection and Immunity · doi:10.1128/iai.01497-07 · Cited by 46
Sevilla, M.-J., & Odds, F. C. (1986) · Microbiology · doi:10.1099/00221287-132-11-3083 · Cited by 46
MacCallum, D. M., Findon, H., Kenny, C. C., Butler, G., Haynes, K., & Odds, F. C. (2006) · Infection and Immunity · doi:10.1128/iai.00817-06 · Cited by 45 · cited 1×
“glabrata lacking Ace2 are hypervirulent (265, 271, 351).”
BackgroundMitogen activated protein kinases of Aspergillus fumigatus
May, G. S., Xue, T., Kontoyiannis, D. P., & Gustin, M. C. (2005) · Medical Mycology · doi:10.1080/13693780400024784 · Cited by 45
Dannaoui, E. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05326-0 · Cited by 45
Fang, W., Yu, X., Wang, B., Zhou, H., Ouyang, H., Ming, J., & Jin, C. (2009) · Microbiology · doi:10.1099/mic.0.029975-0 · Cited by 45
Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences
Byrnes, E. J., & Heitman, J. (2009) · F1000 Biology Reports · doi:10.3410/b1-62 · Cited by 45
Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis
Moosa, M.-Y. S. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.209 · Cited by 43
Research works printed but not linked: 6
- Clinical Laboratory Standards Institute 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. Approved standard M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
- 10.1111/j.1574-6968.2001.tb10853.x · doi:10.1111/j.1574-6968.2001.tb10853.x · Paper page
- 10.1128/am.25.2.309-312.1973 · doi:10.1128/am.25.2.309-312.1973 · Paper page
- 10.1091/mbc.e03-11-0782 · DOI · Paper page
- Kwon-ChungK. J. BennettJ. E.. 1992. Medical Mycology. Lea & Febiger, Philadelphia, PA.
- PrasadT.. 2010. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res. 10:587–596.
Cited by
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
“Elevated chitin content following echinocandin exposure is also observed in C. tropicalis, C. parapsilosis, and Candida guillermondii, in addition Cell wall stress Target alteration or overexpression Up-regulation of multidrug transporters Cellular stress responses - Mediators of stress-response pathways include: Hsp9…”
BackgroundInfluentialSelf-citationAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“fumigatus, and that it is observed in an invertebrate model of candidiasis (Cowen et al. 2009; Singh et al. 2009; Shapiro et al. 2011).”
BackgroundCandida albicans cell-type switching and functional plasticity in the mammalian host
Noble, S. M., Gianetti, B. A., & Witchley, J. N. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.157 · Cited by 521
Metadata
- Authors
- Shapiro, R. S., Robbins, N., & Cowen, L. E.
- Affiliations
- University of Toronto (CA)
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-06
- Volume
- 75
- Issue
- 2
- Pages
- 213-267
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- PMC
- PMC3122626
- OpenAlex
- W2114409750
- Cited by
- 576
- References
- 662
- Citations by year
- 2026: 21 · 2025: 35 · 2024: 34 · 2023: 33 · 2022: 33 · 2021: 44 · 2020: 51 · 2019: 51 · 2018: 46 · 2017: 51 · 2016: 27 · 2015: 43 · 2014: 35 · 2013: 34 · 2012: 32
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology and Molecular Biology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (MOP-86452)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- fungal pathogens, signal transduction, fungal morphogenesis, drug resistance, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, yeast-to-hypha transition, drug target alterations, cellular stress response, fungal virulence, opportunistic fungal infection, conserved signaling pathways
- MeSH terms
- Antifungal Agents, Fungi, Humans, Mycoses, Signal Transduction, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.